Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,316 | -7,710 | -15,001 | -8,412 | -16,330 |
| Depreciation Amortization | 20 | 8 | 9,601 | 9,818 | 9,721 |
| Accounts receivable | 3,339 | 2,905 | -2,300 | 7 | 21 |
| Accounts payable and accrued liabilities | 656 | -1,085 | -1,820 | -2,958 | -1,678 |
| Other Working Capital | -429 | -3,093 | -15,102 | -21,633 | -22,200 |
| Other Operating Activity | -2,179 | -1,344 | 6,392 | 4,937 | 3,216 |
| Operating Cash Flow | $-14,909 | $-10,319 | $-18,230 | $-18,241 | $-27,250 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,699 | 1,754 | -7,535 | -2,531 | -33 |
| PPE Investments | N/A | N/A | 1,219 | 1,227 | 1,221 |
| Investing Cash Flow | $-6,699 | $1,754 | $-6,316 | $-1,304 | $1,188 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -11,612 | -8,517 | -5,593 |
| Common Stock Issued | 15,420 | 2 | 10,486 | 10,495 | 6,115 |
| Other Financing Activity | -115 | -15 | 0 | 0 | 0 |
| Financing Cash Flow | $20,305 | $-13 | $-1,126 | $1,978 | $522 |
| Beginning Cash Position | 26,634 | 26,634 | 52,306 | 52,306 | 52,306 |
| End Cash Position | 25,331 | 18,056 | 26,634 | 34,739 | 26,766 |
| Net Cash Flow | $-1,303 | $-8,578 | $-25,672 | $-17,567 | $-25,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,909 | -10,319 | -18,230 | -18,241 | -27,250 |
| Capital Expenditure | N/A | N/A | -22 | -14 | N/A |
| Free Cash Flow | -14,909 | -10,319 | -18,252 | -18,255 | -27,250 |